U.S. Markets closed

Understanding Xencor’s Technology Partner Programs

Kenneth Smith
Understanding Xencor’s Technology Partner Programs

Xencor’s (XNCR) XmAb Fc domain technology is a platform of antibody components that help in creating antibody candidates. Xencor selectively licenses its XmAb technology to other companies for the internal development of candidates and potential next-generation improvements to their marketed products. In consideration, Xencor is entitled to receive up-front fees, annual licensing fees, potential milestone payments, and royalties on the sales of the resulting products.